Migraine, Market

Migraine Market Enters New Era Following Satsuma Pharmaceuticals' ATZUMI and Amneal Pharmaceuticals' BREKIYA Regulatory Approval | DelveInsight

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom

 
+14699457679

Logo:  https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/migraine-market-enters-new-era-following-satsuma-pharmaceuticals-atzumi-and-amneal-pharmaceuticals-brekiya-regulatory-approval--delveinsight-302461477.html

en | boerse | 67942748 |